D
Elanco Animal Health Incorporated ELAN
$10.41 -$0.40-3.70%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
D
Sell 11/8/2024Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D from D- on 11/8/2024 due to a substantial increase in the efficiency index, valuation index and growth index. Net income increased 828% from -$50M to $364M, and earnings per share increased from -$0.1012 to $0.73.
D
Sell 1/25/2024Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D- from E+ on 1/25/2024 due to an increase in the volatility index and total return index.
E
Sell 1/9/2024Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to E+ from D- on 1/9/2024 due to a decline in the volatility index and valuation index.
D
Sell 12/11/2023Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D- from E+ on 12/11/2023 due to an increase in the total return index and volatility index.
E
Sell 11/24/2023Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to E+ from D- on 11/24/2023 due to a decline in the volatility index and valuation index.
D
Sell 11/8/2023Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D- from E+ on 11/8/2023 due to an increase in the valuation index, volatility index and total return index.
E
Sell 3/14/2023Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index.
D
Sell 3/2/2023Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D from D- on 3/2/2023 due to a substantial increase in the growth index, solvency index and total return index. Debt to equity declined from 0.87 to 0.8.
D
Sell 2/23/2023Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell 2/8/2023Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index, solvency index and volatility index. The quick ratio declined from 1.24 to 0.92, and debt to equity increased from 0.85 to 0.87.
D
Sell 10/4/2022Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D- from D on 10/4/2022 due to a decline in the volatility index and total return index.
D
Sell 9/19/2022Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D from D- on 9/19/2022 due to an increase in the volatility index.
D
Sell 8/31/2022Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D- from D on 8/31/2022 due to a significant decline in the growth index, total return index and volatility index. Earnings per share declined from $0.0984 to -$0.045, EBIT declined 24.44% from $180M to $136M, and total revenue declined 3.92% from $1.23B to $1.18B.
D
Sell 5/16/2022Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell 5/13/2022Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to E+ from D on 5/13/2022 due to a decline in the valuation index, volatility index and total return index.
D
Sell 5/5/2022Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell 4/20/2022Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D- from D on 04/20/2022.
D
Sell 3/21/2022Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D from D+ on 3/21/2022 due to a decline in the volatility index and total return index.
D
Sell 3/2/2022Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D+ from D on 3/2/2022 due to a significant increase in the growth index and solvency index. Operating cash flow increased 150.56% from $89M to $223M, and earnings per share increased from -$0.2134 to -$0.2001.
D
Sell 12/13/2021Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D from D+ on 12/13/2021 due to a decline in the total return index and volatility index.
D
Sell 11/9/2021Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D+ from D- on 11/09/2021.
D
Sell 11/8/2021Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D- from D+ on 11/8/2021 due to a decline in the solvency index. Debt to equity increased from 0.77 to 0.83.
D
Sell 5/20/2021Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D+ from D on 5/20/2021 due to a major increase in the total return index, volatility index and valuation index.
D
Sell 2/28/2020Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D from D+ on 2/28/2020 due to a major decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.0269 to -$0.0287, net income declined 195% from $10M to -$9.5M, and EBIT declined 26.22% from $98M to $72.3M.
D
Sell 1/22/2020Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D+ from D on 1/22/2020 due to an increase in the volatility index and total return index.
D
Sell 1/2/2020Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D from D+ on 1/2/2020 due to a decline in the valuation index, efficiency index and volatility index.
D
Sell 12/17/2019Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D+ from D on 12/17/2019 due to an increase in the volatility index and total return index.
D
Sell 11/12/2019Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D from D+ on 11/12/2019 due to a major decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.0982 to $0.0269, net income declined 72.14% from $35.9M to $10M, and operating cash flow declined 24.71% from $52.6M to $39.6M.
D
Sell 11/7/2019Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D+ from C- on 11/7/2019 due to a noticeable decline in the volatility index and total return index.
C
Hold 8/15/2019Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to C- from D+ on 8/15/2019 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 839.29% from $5.6M to $52.6M, EBIT increased 14.5% from $93.1M to $106.6M, and earnings per share increased from $0.0861 to $0.0982.
D
Sell 8/13/2019Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D+ from C- on 8/13/2019 due to a decline in the volatility index and total return index.
C
Hold 6/19/2019Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to C- from D+ on 6/19/2019 due to an increase in the volatility index, growth index and valuation index.
D
Sell 5/16/2019Upgraded
Elanco Animal Health Incorporated (ELAN) was upgraded to D+ from D on 5/16/2019 due to an increase in the volatility index, efficiency index and solvency index. Net income increased 92.07% from $16.4M to $31.5M, the quick ratio increased from 1.22 to 1.55, and total capital increased 0.95% from $7.67B to $7.74B.
D
Sell 2/11/2019Downgrade
Elanco Animal Health Incorporated (ELAN) was downgraded to D from D+ on 2/11/2019 due to a noticeable decline in the growth index, volatility index and efficiency index.
D
Sell 12/14/2018None
Elanco Animal Health Incorporated (ELAN) was downgraded to D+ from U on 12/14/2018.
Weiss Ratings